Results 11 to 20 of about 17,596 (298)

Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis

open access: yesRadiation Oncology, 2023
Background To investigate whether the rate of stereotactic body radiation therapy-related (SBRT-related) genitourinary (GU) toxicity is lower in patients with prostate cancer treated with CyberKnife.
Makoto Ito   +9 more
doaj   +2 more sources

CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Oncology, 2021
Background and ObjectivePossible treatment strategies for recurrent malignant gliomas include surgery, chemotherapy, radiotherapy, and combined treatments. Among different reirradiation modalities, the CyberKnife System has shown promising results.
Lucio De Maria   +10 more
doaj   +2 more sources

Influence of Specific Treatment Parameters on Nontarget and Out-of-Field Doses in a Phantom Model of Prostate SBRT with CyberKnife and TrueBeam

open access: yesLife, 2022
The aim of the study was to determine the influence of a key treatment plan and beam parameters on overall dose distribution and on doses in organs laying in further distance from the target during prostate SBRT.
Marta Kruszyna-Mochalska   +10 more
doaj   +2 more sources

Stereotactic radiosurgery with Cyberknife®: first case in the United Arab Emirates: a case report

open access: goldThe Pan African Medical Journal, 2022
A 64-year-old gentleman was referred to the department of oncology with severe pain in the right ear radiating to the right side of the face. Imaging revealed a large extra-axial expansile lesion, surrounding and encasing the right cavernous sinus ...
Nandan M Shanbhag   +5 more
openalex   +2 more sources

Cyberknife Radiosurgery for the Treatment of Head and Neck Cancer: A Systematic Review [PDF]

open access: hybridEuropean Journal of Dentistry, 2021
Cyberknife radiosurgery is a frameless stereotactic robotic radiosurgery which has shown to deliver better treatment outcomes in the treatment of advanced head and neck (H&N) carcinomas, especially in previously irradiated and recurrent cases. The aim of
Cristalle Soman   +3 more
openalex   +2 more sources

Pseudoprogression of Vestibular Schwannoma after Stereotactic Radiosurgery with Cyberknife®: Proposal for New Response Criteria

open access: yesCancers, 2023
Simple Summary After stereotactic radiosurgery of vestibular schwannomas, there may be a transient increase in tumor volume. Therefore, it is difficult to distinguish between tumor growth and treatment-related volume changes.
D. Ruess   +9 more
semanticscholar   +1 more source

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience

open access: yesBMC Cancer, 2021
Background The optimal treatment for recurrent high-grade gliomas (rHGGs) remains uncertain. This study aimed to investigate the efficacy and safety of hypofractionated stereotactic radiosurgery (HSRS) as a first-line salvage treatment for in-field ...
Yun Guan   +14 more
doaj   +1 more source

Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors

open access: yesBMC Cancer, 2023
Background The CyberKnife system features a robotically-positioned linear accelerator to deliver real-time image-guided stereotactic ablative body radiotherapy (SABR).
Kazuhiko Hayashi   +16 more
semanticscholar   +1 more source

Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial

open access: yesFrontiers in Oncology, 2023
Simple summary Stereotactic body radiotherapy (SBRT) of 35–36.25 Gy in five fractions with the CyberKnife System yields excellent control with low toxicity in low–intermediate-risk prostate cancer patients.
V. Borzillo   +18 more
semanticscholar   +1 more source

Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT

open access: yesRadiation Oncology, 2023
Background Stereotactic radiotherapy (SRT) and hypo-fractionated radiotherapy are feasible treatment options for single glioblastoma multiforme when combined with conventional radiotherapy or delivered alone.
Mingyuan Pan   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy